Radboudumc and partners ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis

17 December 2021

ATRO Medical, a Radboudumc and DSM spin-off, is based in Uden and has an office in Nijmegen, where the company benefits from the expertise and facilities of Radboudumc. Jan Hunik, co-founder and CEO: "I am very pleased with this investment round and welcomes the trust in the Trammpolin® device at this stage of the development. The funds raised will enable the company to execute a second clinical study to demonstrate its potential to improve the quality of lives of patients".

Read the full article on ATRO Medical

image courtesy of ATRO Medical

Related news items


ATRO Medical starts unique meniscus study

1 November 2024

As the first worldwide, ATRO Medical is starting a clinical study on the function of an artificial outer meniscus, the lateral meniscus. This is a first: never before has a removed lateral meniscus been replaced by a plastic specimen, the Artimis® Meniscus Prosthesis.

read more

Third Radboudumc Investment Day again well-attended

16 October 2023

On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.

read more

Soteria Medical BV announces collaboration with ALLEAD

27 July 2023

Radboudumc spin-off Soteria Medical BV announces collaboration with ALLEAD.

read more

Boosting the startup ecosystem in Nijmegen!

22 June 2023

TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.

read more

Survey of patients to address knee pain from removed meniscus

19 November 2021 Patients with persistent knee pain after meniscus removal can participate at three locations in the Netherlands in the AIR2 study by ATRO Medical, a spin-off of the Radboudumc and DSM. read more